- Home
- DOV vs GH Comparison
DOV vs GH Comparison
Compare DOV & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOV | GH |
|---|---|---|
| Founded | 1947 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.5B | 22.9B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DOV | GH |
|---|---|---|
| Price | $188.87 | $174.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 26 |
| Target Price | ★ $244.84 | $197.04 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 10-22-2026 | 10-28-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | N/A | ★ 6.74 |
| EPS | ★ 4.06 | N/A |
| Revenue | ★ $6,992,118,000.00 | $982,021,000.00 |
| Revenue This Year | $7.14 | $38.25 |
| Revenue Next Year | $5.01 | $35.51 |
| P/E Ratio | $46.62 | ★ N/A |
| Revenue Growth | 2.51 | ★ 32.88 |
| 52 Week Low | $158.97 | $61.00 |
| 52 Week High | $237.54 | $183.51 |
Technical Indicators
Market Signals| Indicator | DOV | GH |
|---|---|---|
| Relative Strength Index (RSI) | 39.49 | 58.97 |
| Support Level | $184.00 | $153.88 |
| Resistance Level | $191.66 | $183.51 |
| Average True Range (ATR) | 3.99 | 7.26 |
| MACD | 0.59 | 0.06 |
| Stochastic Oscillator | 37.16 | 78.42 |
Price Performance
Historical ComparisonAbout DOV Dover Corporation
Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.